BBA - Molecular Basis of Disease

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Nutraceuticals as therapeutic agents for atherosclerosis

  2018influential reference
• Polyunsaturated Fatty Acids and Atherosclerosis: Insights from Pre-Clinical Studies

  2018cited by this paper
• TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice

  2017cited by this paper
• Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients

  2017cited by this paper
• Statin Therapy: Review of Safety and Potential Side Effects.

  2016cited by this paper
• Nutraceutical therapies for atherosclerosis

  2016influential reference
• Hyperglycemia induced damage to mitochondrial respiration in renal mesangial and tubular cells: Implications for diabetic nephropathy

  2016cited by this paper
• A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro

  2016influential reference
• The role of mitogen-activated protein kinases and sterol receptor coactivator-1 in TGF-β-regulated expression of genes implicated in macrophage cholesterol uptake

  2016influential reference
• The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis.

  2015influential reference
• Atherosclerosis: Recent trials, new targets and future directions.

  2015cited by this paper
• Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets

  2015influential reference
• Cytokines

  2015influential reference
• Oral administration of whole dihomo-γ-linolenic acid-producing Saccharomyces cerevisiae suppresses cutaneous inflammatory responses induced by croton oil application in mice

  2014cited by this paper
• Differential regulation of macropinocytosis in macrophages by cytokines: Implications for foam cell formation and atherosclerosis☆

  2013cited by this paper
• Macrophages

  2013cited by this paper
• Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.

  2013cited by this paper
• Polyunsaturated fatty acid relatively decreases cholesterol content in THP-1 macrophage-derived foam cell: partly correlates with expression profile of CIDE and PAT members

  2013influential reference
• TGF-β inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: A dominant role for Smad-2

  2012influential reference
• Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action.

  2012influential reference
• Macrophages, lipid metabolism and gene expression in atherogenesis: a therapeutic target of the future?

  2012cited by this paper
• Oral Supplementation with Dihomo-γ-Linolenic Acid (DGLA)-Enriched Oil Increases Serum DGLA Content in Healthy Adults

  2012cited by this paper
• The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.

  2012cited by this paper
• Mitochondria in vascular disease.

  2012cited by this paper
• Assessing bioenergetic function in response to oxidative stress by metabolic profiling.

  2011cited by this paper
• Assessing mitochondrial dysfunction in cells

  2011cited by this paper
• Eicosapentaenoic Acid and Docosahexaenoic Acid Regulate Modified LDL Uptake and Macropinocytosis in Human Macrophages

  2011cited by this paper
• Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.

  2011cited by this paper
• STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.

  2011cited by this paper
• Polyunsaturated Fatty Acids and Modulation of Cholesterol Homeostasis in THP-1 Macrophage-Derived Foam Cells

  2010cited by this paper
• IL-33 Reduces Macrophage Foam Cell Formation

  2010influential reference
• A defect in Δ6 and Δ5 desaturases may be a factor in the initiation and progression of insulin resistance, the metabolic syndrome and ischemic heart disease in South Asians

  2010cited by this paper
• Effect of endothelial cell proliferation on atherogenesis: a role of p21(Sdi/Cip/Waf1) in monocyte adhesion to endothelial cells.

  2010cited by this paper
• ERK Is Integral to the IFN-γ–Mediated Activation of STAT1, the Expression of Key Genes Implicated in Atherosclerosis, and the Uptake of Modified Lipoproteins by Human Macrophages

  2010cited by this paper
• ADAMTS-7 Mediates Vascular Smooth Muscle Cell Migration and Neointima Formation in Balloon-Injured Rat Arteries

  2009cited by this paper
• Oral Supplementation with Dihomo-γ-linolenic Acid-Enriched Oil Altered Serum Fatty Acids in Healthy Men

  2009cited by this paper
• Interferon gamma: a master regulator of atherosclerosis.

  2009influential reference
• Subchronic (13-week) oral toxicity study of dihomo-gamma-linolenic acid (DGLA) oil in rats.

  2009cited by this paper
• Anti-atherosclerotic effects of dihomo-gamma-linolenic acid in ApoE-deficient mice.

  2009influential reference
• Signal Transducer and Activator of Transcription 1 Is Required for Optimal Foam Cell Formation and Atherosclerotic Lesion Development

  2007cited by this paper
• Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element.

  2007cited by this paper
• Critical Role for Casein Kinase 2 and Phosphoinositide-3-Kinase in the Interferon-&ggr;–Induced Expression of Monocyte Chemoattractant Protein-1 and Other Key Genes Implicated in Atherosclerosis

  2007cited by this paper
• Effect of dihomogammalinolenic acid and its 15-lipoxygenase metabolite on eicosanoid metabolism by human mononuclear leukocytes in vitro: selective inhibition of the 5-lipoxygenase pathway

  2004cited by this paper
• The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression.

  2003cited by this paper
• Liver X Receptors

  2002cited by this paper
• Importance of dietary gamma-linolenic acid in human health and nutrition.

  1998cited by this paper
• Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease.

  1995cited by this paper
• Utilization of gammalinolenic acid by mouse peritoneal macrophages.

  1991cited by this paper
• Suppression of human synovial cell proliferation by dihomo-gamma-linolenic acid.

  1989cited by this paper
• Low prevalences of coronary heart disease (CHD), psoriasis, asthma and rheumatoid arthritis in Eskimos: are they caused by high dietary intake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both?

  1987cited by this paper
• Dihomo-gamma-linolenic acid reverses hypertension induced in rats by diets rich in saturated fat.

  1984cited by this paper
• Antithrombotic potential of dihomo-gamma-linolenic acid in man.

  1977cited by this paper
• The rapid incorporation of phosphate into mitochondrial lipids.

  1963cited by this paper

• No citing papers are available for this paper.